Nature of Operations and Liquidity - Additional Information (Detail) - USD ($) $ in Thousands		3 Months Ended				6 Months Ended
	Oct. 30, 2023	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Organization And Nature Of Operations [Line Items]
Net income		$ 4,538	$ 9,935	$ 3,770	$ 4,217	$ 14,500
Net cash used in operating activities						2,609	$ (14,950)
Accumulated deficit		74,478				74,478		$ 85,538
Cash and cash equivalents		$ 16,097				$ 16,097		$ 33,509
Gyre | Gyre Pharmaceuticals
Organization And Nature Of Operations [Line Items]
Minority interest ownership indirectly holds	65.20%